Compare J.B.Chemicals with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PANACEA BIOTECH - Comparison Results

J.B.CHEMICALS     Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PANACEA BIOTECH J.B.CHEMICALS/
PANACEA BIOTECH
 
P/E (TTM) x 21.5 6.5 331.2% View Chart
P/BV x 3.9 2.5 153.0% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 J.B.CHEMICALS   PANACEA BIOTECH
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
PANACEA BIOTECH
Mar-19
J.B.CHEMICALS/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs363354 102.7%   
Low Rs255138 184.5%   
Sales per share (Unadj.) Rs169.174.6 226.8%  
Earnings per share (Unadj.) Rs16.66.7 248.5%  
Cash flow per share (Unadj.) Rs23.415.5 151.1%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.557.2 301.5%  
Shares outstanding (eoy) m83.5761.25 136.4%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.83.3 55.4%   
Avg P/E ratio x18.636.8 50.6%  
P/CF ratio (eoy) x13.215.9 83.2%  
Price / Book Value ratio x1.84.3 41.7%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,82715,061 171.5%   
No. of employees `0003.82.3 163.0%   
Total wages/salary Rs m2,5111,471 170.7%   
Avg. sales/employee Rs Th3,747.41,973.6 189.9%   
Avg. wages/employee Rs Th665.7635.6 104.7%   
Avg. net profit/employee Rs Th367.8176.8 208.0%   
INCOME DATA
Net Sales Rs m14,1354,567 309.5%  
Other income Rs m36645 816.5%   
Total revenues Rs m14,5014,612 314.4%   
Gross profit Rs m2,1782,030 107.3%  
Depreciation Rs m570540 105.5%   
Interest Rs m351,048 3.3%   
Profit before tax Rs m1,940486 398.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m55277 716.3%   
Profit after tax Rs m1,387409 339.1%  
Gross profit margin %15.444.4 34.7%  
Effective tax rate %28.515.9 179.6%   
Net profit margin %9.89.0 109.6%  
BALANCE SHEET DATA
Current assets Rs m10,4702,415 433.6%   
Current liabilities Rs m2,7499,077 30.3%   
Net working cap to sales %54.6-145.9 -37.4%  
Current ratio x3.80.3 1,431.9%  
Inventory Days Days5565 84.8%  
Debtors Days Days7871 109.5%  
Net fixed assets Rs m5,8118,333 69.7%   
Share capital Rs m16761 272.6%   
"Free" reserves Rs m14,2483,443 413.9%   
Net worth Rs m14,4163,504 411.4%   
Long term debt Rs m0461 0.0%   
Total assets Rs m17,64913,755 128.3%  
Interest coverage x56.61.5 3,864.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.3 241.2%   
Return on assets %8.110.6 76.1%  
Return on equity %9.611.7 82.4%  
Return on capital %13.738.7 35.4%  
Exports to sales %020.9 0.0%   
Imports to sales %08.1 0.0%   
Exports (fob) Rs mNA954 0.0%   
Imports (cif) Rs mNA372 0.0%   
Fx inflow Rs m6,1641,203 512.4%   
Fx outflow Rs m1,334467 286.0%   
Net fx Rs m4,829736 655.8%   
CASH FLOW
From Operations Rs m1,2311,049 117.3%  
From Investments Rs m-208-54 389.0%  
From Financial Activity Rs m-595-1,011 58.8%  
Net Cashflow Rs m427-20 -2,168.0%  

Share Holding

Indian Promoters % 55.4 74.5 74.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.6 565.0%  
FIIs % 3.9 1.3 300.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 23.6 156.8%  
Shareholders   30,437 10,259 296.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  UNICHEM LAB  NATCO PHARMA  ELDER PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 260 Points Lower; Finance and Banking Stocks Witness Huge Selling(Closing)

Indian share markets witnessed negative trading activity today and ended their trading session lower.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

Protect Your Wealth from Fund Managers(Fast Profits Daily)

May 14, 2020

Do you know how much you are paying in fees to your mutual fund? In this video I'll share with you my views.

Covid-19 Offers a Rare Opportunity to Own This Brand Leader(Profit Hunter)

May 12, 2020

Covid-19 has compounded uncertainties in investing but this smallcap company is strong enough to survive and even emerge stronger.

Of India's 20 Trillion Stimulus Package and the Swoosh Index for a Swoosh Recovery(Profit Hunter)

May 13, 2020

For India's rapid economic recovery, hopping on to the Swoosh index is a must.

How Commodity Prices Tell You When Stocks Will Go Up(Fast Profits Daily)

May 20, 2020

Commodity prices often provide clues to big moves in stock markets. In today's video, I'll explain this link.

Why Buffet - and you - should study Quantum Liquid Fund(The Honest Truth)

May 14, 2020

Ajit Dayal on how Quantum Liquid Fund and Warren Buffett have similar investing styles.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 22, 2020 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS